ATEX Technologies

What ATEX Technologies does

ATEX Technologies, Inc., founded in 2004 and headquartered in Pinebluff, North Carolina, designs and manufactures custom implantable textile components for medical device OEMs. The company is a 51-100 employee specialty textile manufacturer operating exclusively in the medical device market, with a portfolio organized around four clinical specialty areas: Vascular and Structural Heart, Orthopedic and Robotic Surgery, General Surgery, and Neurology and Regenerative Medicine. Components include vascular grafts, structural heart valve fabrics, stent grafts, transcatheter valve fabrics, high-strength braided sutures, surgical mesh, pledgets, embolic protection devices, thrombus retrieval textiles, and tissue engineering scaffolds.

ATEX's technology stack is built on vertically integrated textile manufacturing. The company operates in-house PET yarn extrusion starting from polymer chips, backed by an FDA Master File for PET that customers can leverage in their regulatory submissions, plus proprietary UHMWPE and LCP fibers for high-strength, low-creep applications. Construction capabilities span knitting (Tricot, Milanese, Raschel), weaving, braiding, non-woven, and hybrid multi-fiber fabrics. Post-processing includes precision laser cutting, heat forming, ultrasonic bonding, custom coatings, fabric marking, and clean room processing under ISO 13485:2016 certified quality systems. Components can be engineered for compression into small delivery catheters and reliable deployment for minimally invasive procedures.

The business model is a custom, engineering-led B2B engagement with medical device manufacturers, organized around a five-phase development process—Project Kick-Off, Feasibility, Development, 1st Article, Transfer to Manufacturing—culminating in commercial production. ATEX does not sell finished devices and does not distribute through third parties; all sales are direct to OEMs, supported by trade show participation at MD&M West (Anaheim, 2024-2026) and MedTec China (Suzhou, 2023). Pricing is not publicly disclosed and is handled through project-based consultation. Revenue is not publicly reported; the company is privately held with no disclosed institutional investors, parent entity, or M&A activity in the source data. The adjacent surgical polypropylene mesh market is projected to reach $3.29 billion by 2030 at a 6.1% CAGR per an external source, indicating a growing tailwind for ATEX's addressable market.

Name

ATEX Technologies

Legal name

ATEX Technologies, Inc.

Website

https://atextechnologies.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

51–100 employees

Short description

ATEX Technologies designs and manufactures custom implantable textile components—including vascular grafts, valve fabrics, sutures, and scaffolds—for medical device OEMs. Vertical integration spans in-house PET yarn extrusion, knitting, weaving, and braiding, backed by an FDA Master File and ISO 13485:2016 certification.

Ownership category

akta.pro rank

Product category

Implantable Medical Textiles

NAICS

Knit Fabric Mills (31324), Fiber, Yarn, and Thread Mills (313110)

akta.pro primary industry

Medical & Hygiene Technical Textiles (Gauze/Drapes/Wipes/Barrier Fabrics) (IMAOADAD)

akta.pro secondary industries

Industrial & Technical Yarn Manufacturing (High-Tenacity/Aramid/Carbon/Glass) (IMAOAAAG), Sewing Thread Manufacturing (IMAOAAAH)

Keywords

• Implantable medical textiles
• Biomedical textile components
• Medical device fabrics
• Custom yarn extrusion
• Surgical textile manufacturing

Headquarters

HQ city

Pinebluff

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Custom Implantable Medical Textile Components: ATEX generates revenue by engineering and manufacturing custom implantable textile components for medical device OEM manufacturers. Components include vascular grafts, heart valve components, surgical sutures, mesh, cables, tethers, pledgets, tissue scaffolds, embolic protection components, and other biomedical textiles. Revenue is generated through custom project-based engagements spanning from feasibility through full-scale production, with customers paying for component development and manufacturing. ATEX does not manufacture finished medical devices.
2. Engineering and Development Services: ATEX provides engineering services including yarn development, textile formation, finishing, testing, and validation as part of its component supply model. These services are bundled with component manufacturing under the company's solutions partner approach.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

ATEX Technologies designs, develops, and manufactures custom implantable textile components for medical device OEM manufacturers. The company produces precision fiber-based components—including vascular grafts, heart valve components, surgical sutures, mesh, cables, tethers, pledgets, tissue scaffolds, and embolic protection devices—using knitting, weaving, braiding, and non-woven textile technologies. ATEX operates a vertically integrated model with in-house PET yarn extrusion and full lifecycle support from concept through commercial production.

Product overview

ATEX Technologies is a medical textile solutions provider specializing in custom implantable textile components and biomedical textiles for medical device manufacturers. The company offers a comprehensive portfolio organized around five clinical specialty areas: Vascular and Structural Heart Solutions (including stent grafts, surgical grafts, and heart valve components), Orthopedic and Robotic Surgery Solutions (sutures, cables, mesh, and soft tissue fixation), General Surgery Solutions (sutures, mesh, pledgets, and tissue scaffolds), and Neurology and Regenerative Medicine Solutions (tissue scaffolds, embolic protection, thrombus retrieval, and nerve conduits). These clinical solutions are built on core technology pillars: Component Shapes (flat sheets, tubes, tapers, bifurcates), Textile Construction Technologies (knitting, weaving, braiding, non-woven, hybrid), Fabrication and Enhancements (laser cutting, coatings, assembly), and Medical-Grade Materials (PET, UHMWPE, PEEK, LCP, nitinol, resorbables). The company manages product development through a five-phase life cycle process from feasibility through manufacturing, providing engineering services for optimizing tensile strength, conformability, porosity, and surface characteristics. ATEX positions itself as a solutions partner rather than a contract manufacturer, focusing on relationship-first collaboration with device manufacturers.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 100% of surveyed customers would recommend ATEX, reflecting high satisfaction with quality, communication, technical capability, and on-time delivery
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Confluent Medical Technologies: Confluent Medical Technologies (formerly Biomedical Structures) is a direct competitor specializing in engineered textile and braided components for implantable medical devices, serving the same structural heart, vascular, and orthopedic OEM customers with overlapping knit, weave, and braid capabilities.
• Secant Group: Secant Group develops custom implantable textile structures and bioresorbable materials for medical devices, directly competing with ATEX in regenerative medicine scaffolds, surgical mesh, and cardiovascular textile components using similar knitting and braiding processes.
• Cortland Biomedical: Cortland Biomedical (formerly part of Bally Ribbon Mills) manufactures high-performance biomedical textile implants including braided sutures, vascular grafts, and orthopedic textile structures, providing direct competition to ATEX's core braided and woven implant offerings.
• Bally Ribbon Mills: Bally Ribbon Mills produces narrow and specialty woven/braided textiles including medical applications such as vascular grafts and implant components. Its 3D weaving capabilities overlap with ATEX's complex 3D biomedical textile structures.

Broad incumbents

• W. L. Gore & Associates: W.L. Gore is a broad incumbent in medical textiles, producing GORE-TEX expanded PTFE vascular grafts, stent grafts, and surgical mesh. While much larger and broader than ATEX, Gore directly competes in the implantable vascular and structural heart textile market.
• DSM Biomedical: DSM Biomedical is a major biomaterials supplier providing polymers and resorbable materials used in implantable medical devices. As a broad incumbent with overlapping material science expertise, DSM competes indirectly with ATEX in advanced implantable materials.

Emerging players

• Polyzen: Polyzen specializes in custom polymer films and coated textiles for medical devices, with emerging capabilities in implantable and disposable medical textile components that partially overlap with ATEX's fabrication and enhancement offerings.
• TissueGen: TissueGen manufactures bioresorbable textile scaffolds and fibers for tissue engineering and regenerative medicine applications, an emerging niche that overlaps with ATEX's neurology and regenerative medicine textile component portfolio.
• U.S. Textile: U.S. Textile is a smaller specialty textile manufacturer serving medical and industrial markets with custom knitting and weaving capabilities. As an emerging player, it competes for some of the same medical textile opportunities as ATEX, though with less implantable focus.

Others

• J-Pac Medical: J-Pac Medical is a contract manufacturer of medical devices and textile-based components, offering absorbable and non-absorbable surgical textile products. While a broader contract manufacturer, it competes for adjacent OEM medical textile work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/atextechnologies

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATEX Technologies